Entest Biomedical Stock Volatility
| ETNI Stock | USD 0.0002 0.00 0.00% |
Entest Biomedical secures Sharpe Ratio (or Efficiency) of -0.13, which denotes the company had a -0.13 % return per unit of risk over the last 3 months. Entest Biomedical exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Entest Biomedical's Standard Deviation of 234.31, mean deviation of 56.74, and Variance of 54899.42 to check the risk estimate we provide.
Sharpe Ratio = -0.126
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ETNI |
Based on monthly moving average Entest Biomedical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entest Biomedical by adding Entest Biomedical to a well-diversified portfolio.
Key indicators related to Entest Biomedical's volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Entest Biomedical Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Entest daily returns, and it is calculated using variance and standard deviation. We also use Entest's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Entest Biomedical volatility.
Entest |
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Entest Biomedical at lower prices. For example, an investor can purchase Entest stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes. Main indicators related to Entest Biomedical's market risk premium analysis include:
Beta (29.42) | Alpha 29.02 | Risk 11.34 | Sharpe Ratio (0.13) | Expected Return (1.43) |
Moving against Entest Pink Sheet
| 0.34 | PBAJ | Petro Usa | PairCorr |
| 0.33 | LION | Lionsgate Studios Holding | PairCorr |
| 0.33 | F | Ford Motor | PairCorr |
| 0.32 | RIVN | Rivian Automotive Earnings Call This Week | PairCorr |
Entest Biomedical Market Sensitivity And Downside Risk
Entest Biomedical's beta coefficient measures the volatility of Entest pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Entest pink sheet's returns against your selected market. In other words, Entest Biomedical's beta of -29.42 provides an investor with an approximation of how much risk Entest Biomedical pink sheet can potentially add to one of your existing portfolios. Entest Biomedical is displaying above-average volatility over the selected time horizon. Entest Biomedical appears to be a penny stock. Although Entest Biomedical may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Entest Biomedical or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Entest instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
| α | 29.02 | β | -29.42 | Check current 90 days Entest Biomedical correlation with market (Dow Jones Industrial)
Entest Biomedical Volatility and Downside Risk
Entest standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Entest Biomedical Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Entest Biomedical pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Entest Biomedical's price changes. Investors will then calculate the volatility of Entest Biomedical's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Entest Biomedical's volatility:
Historical Volatility
This type of pink sheet volatility measures Entest Biomedical's fluctuations based on previous trends. It's commonly used to predict Entest Biomedical's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Entest Biomedical's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Entest Biomedical's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Entest Biomedical Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Entest Biomedical Projected Return Density Against Market
Given the investment horizon of 90 days Entest Biomedical has a beta of -29.422 suggesting as returns on its benchmark rise, returns on holding Entest Biomedical are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Entest Biomedical is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Entest Biomedical or Financial Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Entest Biomedical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Entest pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Predicted Return Density |
| Returns |
What Drives an Entest Biomedical Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Entest Biomedical Pink Sheet Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Entest Biomedical is -793.73. The daily returns are distributed with a variance of 128.57 and standard deviation of 11.34. The mean deviation of Entest Biomedical is currently at 2.81. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.74
α | Alpha over Dow Jones | 29.02 | |
β | Beta against Dow Jones | -29.42 | |
σ | Overall volatility | 11.34 | |
Ir | Information ratio | 0.12 |
Entest Biomedical Pink Sheet Return Volatility
Entest Biomedical historical daily return volatility represents how much of Entest Biomedical pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 11.3389% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7533% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Entest Pink Sheet performing well and Entest Biomedical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Entest Biomedical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BFYW | 1.49 | (0.72) | 0.00 | 0.87 | 0.00 | 0.00 | 50.00 | |||
| DHCC | 49.18 | 23.84 | 0.35 | (0.68) | 17.67 | 33.33 | 1,326 | |||
| USCS | 7.48 | 1.05 | 0.00 | (1.08) | 0.00 | 0.00 | 150.00 | |||
| USRI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CHYL | 3,578 | 1,809 | 0.00 | 19.10 | 0.00 | 0.00 | 119,975 | |||
| APWL | 1.51 | 0.21 | 0.00 | 0.36 | 0.00 | 0.00 | 83.33 | |||
| PBAJ | 4.48 | 2.08 | 0.00 | 0.67 | 0.00 | 0.00 | 150.00 | |||
| TGMR | 7.73 | 2.75 | 0.00 | (0.62) | 0.00 | 0.00 | 297.23 | |||
| AAGC | 8.28 | 0.90 | 0.05 | 2.83 | 8.58 | 20.00 | 54.29 | |||
| EXBX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
About Entest Biomedical Volatility
Volatility is a rate at which the price of Entest Biomedical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Entest Biomedical may increase or decrease. In other words, similar to Entest's beta indicator, it measures the risk of Entest Biomedical and helps estimate the fluctuations that may happen in a short period of time. So if prices of Entest Biomedical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.It intends to seek business opportunities to review and analyze for purposes of effecting a merger, acquisition, or other business combination with an operating company business. Entest Group, Inc. was founded in 2008 and is based in Shenzhen, China. Entest is traded on OTC Exchange in the United States.
Entest Biomedical's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Entest Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Entest Biomedical's price varies over time.
3 ways to utilize Entest Biomedical's volatility to invest better
Higher Entest Biomedical's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Entest Biomedical stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Entest Biomedical stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Entest Biomedical investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Entest Biomedical's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Entest Biomedical's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Entest Biomedical Investment Opportunity
Entest Biomedical has a volatility of 11.34 and is 15.12 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than Entest Biomedical. You can use Entest Biomedical to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of Entest Biomedical to be traded at $2.0E-4 in 90 days.Very good diversification
The correlation between Entest Biomedical and DJI is -0.25 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Entest Biomedical and DJI in the same portfolio, assuming nothing else is changed.
Entest Biomedical Additional Risk Indicators
The analysis of Entest Biomedical's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Entest Biomedical's investment and either accepting that risk or mitigating it. Along with some common measures of Entest Biomedical pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0961 | |||
| Market Risk Adjusted Performance | (0.92) | |||
| Mean Deviation | 56.74 | |||
| Coefficient Of Variation | 854.38 | |||
| Standard Deviation | 234.31 | |||
| Variance | 54899.42 | |||
| Information Ratio | 0.1168 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Entest Biomedical Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Entest Biomedical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Entest Biomedical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Entest Biomedical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Entest Biomedical.
Complementary Tools for Entest Pink Sheet analysis
When running Entest Biomedical's price analysis, check to measure Entest Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entest Biomedical is operating at the current time. Most of Entest Biomedical's value examination focuses on studying past and present price action to predict the probability of Entest Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entest Biomedical's price. Additionally, you may evaluate how the addition of Entest Biomedical to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |